University Health Network
Toronto, Ontario, M5G2C4, Canada
NCT Number: NCT04248959
The purpose of this study was to evaluate the feasibility of a multimodal prehabilitation intervention intended to optimize postoperative recovery in adolescents and young adults (AYAs) diagnosed with soft tissue and bone-based sarcomas of the upper and lower extremities (extremity sarcomas; ES).
Looking for future studies?
Notify Me18 year–39 year
All sexes
Interventional
Not applicable
Toronto, Ontario, M5G2C4, Canada
Objectives:
This objective of this study was to investigate the feasibility of multimodal prehabilitation for adolescents and young adults (AYAs) diagnosed with soft tissue and bone-based sarcomas of the upper and lower extremities (extremity sarcomas; ES) and explore its effects on measurements of health-related quality of life, physical function, length of hospital stays, and post-operative complications. Specific aims of the study included:
Methods:
A single-arm, proof-of-concept trial design was informed by the ORBIT model of behavioural treatment development. Mixed methods were employed to obtain relevant context for investigating the feasibility of multimodal prehabilitation in newly diagnosed AYAs with ES within the circumstances of the COVID-19 pandemic.
Participants underwent virtual multimodal prehabilitation before undergoing major extremity sarcoma surgery. This program encompassed personalized exercise, nutrition, and stress management support delivered by a registered kinesiologist, registered dietitian, and clinical psychologist, respectively. The interventions were designed to enhance physical and psychological resilience to stress, with the objective of improving recovery outcomes and mitigating the risk of adverse events.
Feasibility (e.g., recruitment, safety, tolerability), physical function, and patient-reported outcomes were measured at baseline (T0), immediately preoperatively (T1), and one month postoperatively (T2).
Feasibility data and field notes were collected by the research coordinators (during recruitment and postoperative follow-up) and by the study lead / research assistants during the intervention period. A postoperative interview explored experiences with prehabilitation into explore the feasibility and practical considerations of virtual prehabilitation for adolescents and young adults with extremity sarcomas.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Multimodal Prehabilitation
Time frame: Initiation through end of study recruitment at 12 months
Defined as the percent of consenting patients based on the total number of otherwise eligible patients (OEP; patients meeting all study eligibility criteria) approached
Time frame: Initiation through end of pre-operative testing
Defined as the number and frequency of testing- and intervention-related serious adverse events (SAEs) according to the Common Terminology Criteria for Adverse Events
Time frame: Initiation through end of study intervention period
Defined as relative dose intensity as the percent of total dose of exercise performed relative to the total planned dose prescribed and quantified according to metabolic equivalents
Time frame: Initiation through end of study recruitmentat 12 months
Defined as the average number of OEP identified each month
Time frame: Initiation through end of study recruitment at 12 months
Defined as the percent of consenting patients who successfully complete baseline assessments based on the total number of consenting patients
Time frame: Initiation through end of study intervention period
Defined as the average elapsed time (in days) between diagnosis and extremity sarcoma surgery
Time frame: Initiation through end of pre-operative testing
Defined as the number and frequency of testing- and intervention-related non-serious adverse events (nSAEs) according to the Common Terminology Criteria for Adverse Events
Time frame: Initiation through end of pre-operative testing
Defined as percent completion physical testing at baseline and follow-up
Time frame: Initiation through end of pre-operative testing
Defined as the percent of all tests which are adapted for functional or safety reasons
Time frame: Initiation through end of study intervention period
Defined as the percent of all exercise sessions which are adapted for functional or safety reasons
Time frame: Initiation through end of study intervention period
Defined as the percent of patients who discontinue intervention participation prior to the planned end of the intervention period
Time frame: Initiation through end of study intervention period
Defined as the percent of patients who miss ≥3 consecutive sessions within the intervention period
Time frame: Initiation through end of study intervention period
Defined as the percent of exercise sessions requiring a dose reduction during training (i.e., intensity or duration) relative to the total number of sessions completed. Total number of exercise sessions with a reduction in intensity or a reduction in duration will be combined into the numerator when calculating the percentage of affected sessions.
Time frame: Initiation through end of study intervention period
Defined as the percent of exercise sessions requiring unplanned early termination
Time frame: Initiation through end of study intervention period
Defined as the percent of sessions which required pre-exercise modification of the target exercise intensity due to a pre-exercise screening indication (e.g., fatigue, pain)
Time frame: Initiation through end of study intervention period
Defined as the percent of exercise sessions completed based on the total number of sessions prescribed
Time frame: Initiation through end of study intervention period
Defined as the percent of psychological sessions completed based on the total number of sessions prescribed
Time frame: Study initiation through end of 1 month postoperative (T2)
Defined as the percent loss to follow-up (not completing follow-up assessments), individually and overall
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Primary exploratory outcome: European Organization for the Research and Treatment of Cancer (EORTC) QLC-C30
Time frame: 1 month postoperative (T2)
Postoperative complication severity and frequency defined according to the Common Terminology Criteria for Adverse Events.
Time frame: 1 month postoperative (T2)
Average postoperative hospitalization period
Time frame: Baseline (T0), preoperative (T1)
Total distance traveled during six-minute walk test
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Godin Leisure-time Exercise Questionnaire
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
EQ-5D; All 5 items are rated on a 1 to 3 scale with higher numbers reflecting worse outcomes.
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Edmonton Symptom Assessment Scale (ESAS); All 10 items are rated on a 0 to 10 scale with higher numbers reflecting worse outcomes.
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Hospital Anxiety and Depression Scale (HADS); All 14 items are rated on a 0 to 3 scale with higher numbers reflecting worse outcomes.
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Functional Assessment of Chronic Illness Therapy-Fatigue scale (FACIT-F); All 13 items are rated on a 0 to 4 scale with higher numbers reflecting worse outcomes.
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Work Limitations Questionnaire
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Medical Outcomes Study Social Support Scale (SF-20); All item scores transformed into 0 to 100 scales with higher scores reflecting better outcomes.
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Experiences in Close Relationships scale (ECR); All 36 items rated on a 1 to 7 scale with higher scores reflecting worse outcomes.
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Toronto Extremity Salvage Score (upper or lower)
Time frame: Baseline (T0), preoperative (T1), 1 month postoperative (T2)
Musculoskeletal Tumor Society score
University Health Network, Toronto
Other
Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity Sarcomas (PICaSO-ES): A Proof-of-Concept Trial
Acronym: PICaSO-ES
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04028479
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Idaho Falls, Idaho, United States
View Trial DetailsNCT06535997
Adenocarcinoma, Angiosarcomas
Caen, France
View Trial DetailsNCT04616248
Adenocarcinoma, Anatomic Stage IV Breast Cancer AJCC v8
Los Angeles, California, United States
View Trial DetailsNCT04122872
Carcinosarcoma, Neoplasms
Tübingen, Baden-Wurttemberg, Germany
View Trial Details